Literature DB >> 25772656

[Sleep quality in patients with ankylosing spondylitis].

Elif Aydin1, Kevser Bayraktar2, Yasemin Turan2, Imran Omurlu3, Engin Tastaban2, Omer Faruk Sendur2.   

Abstract

INTRODUCTION: Ankylosing spondylitis (AS) is a chronic, inflammatory rheumatic disease characterized by the inflammation of the pelvis and spine that results in a restriction in the mobility of the spine. Due to the altered posture and nocturnal inflammatory pain, sleep disturbances are likely to occur in patients with AS.
OBJECTIVE: This cross-sectional study aimed at determining the differences between the patients with AS and healthy controls in sleep quality, as well as assessing the relationship between the sleep quality and disease activity.
METHOD: In order to assess sleep quality, fifty-five patients with AS (40 men, 15 women; mean age, 43 ± 1 yrs) who fulfilled the modified New York criteria and fifty-five comparable controls (40 men, 15 women; mean age, 42 ± 9 yrs) completed the Pittsburgh Sleep Quality Index (PSQI) questionnaire. The disease activity was assessed by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
RESULTS: Ankylosing spondylitis was associated with a significantly impaired sleep quality according to the total PSQI scores (p = 0.001). Significant differences were found between the patients with AS and healthy controls in PSQI domains, including "subjective sleep quality" (p = 0. 010), "sleep duration" (p = 0. 011), "habitual sleep efficiency" (p = 0. 034), "sleep disturbances" (p = 0. 003) and "daytime dysfunction" (p = 0. 009) but not in "sleep latency", "use of sleep medication". There was a significant positive correlation between the BASDAI and PSQI scores (r = 0.612, p = 0.001).
CONCLUSION: In the current study, we found that the sleep disturbances were significantly higher in patients with AS in comparison to controls. Patients with active disease had worse sleep quality. In addition, disease activity was correlated with the scores of most of the PSQI subscales. Sleep quality assessment should be a tool for evaluating patients with AS.
Copyright © 2015 Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Atividade da doença; Disease activity; Espondilite anquilosante; Pittsburgh Sleep Quality Index; Qualidade do sono; Sleep quality; Índice de Qualidade do Sono de Pittsburgh

Mesh:

Year:  2015        PMID: 25772656     DOI: 10.1016/j.rbr.2014.12.007

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  9 in total

Review 1.  Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review.

Authors:  Shaaron Leverment; Emily Clarke; Alison Wadeley; Raj Sengupta
Journal:  Rheumatol Int       Date:  2016-10-28       Impact factor: 2.631

2.  Prevalence and factors associated with disturbed sleep in outpatients with ankylosing spondylitis.

Authors:  Anliu Nie; Chen Wang; Yuqing Song; Xia Xie; Hui Yang; Hong Chen
Journal:  Clin Rheumatol       Date:  2018-07-03       Impact factor: 2.980

3.  Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood.

Authors:  Alison Wadeley; Emily Clarke; Shaaron Leverment; Raj Sengupta
Journal:  Clin Rheumatol       Date:  2018-01-19       Impact factor: 2.980

4.  Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.

Authors:  Sara F Milrad; Daniel L Hall; Devika R Jutagir; Emily G Lattie; Gail H Ironson; William Wohlgemuth; Maria Vera Nunez; Lina Garcia; Sara J Czaja; Dolores M Perdomo; Mary Ann Fletcher; Nancy Klimas; Michael H Antoni
Journal:  J Neuroimmunol       Date:  2016-12-14       Impact factor: 3.478

5.  Functional and psychosocial impact of COVID-19 pandemic on rheumatic patients' quality of life in Saudi Arabia.

Authors:  Lena M Hassen; Rana A Albarrak; Reem A Albahlal; Dimah K Alsaqabi; Ikhlass M Hassen; Maha H Daghestani; Eman M Alqurtas; Abdulaziz T Alkhalaf; Mohammed K Bedaiwi; Mohammed A Omair; Ibrahim A Almaghlouth
Journal:  Qual Life Res       Date:  2022-07-20       Impact factor: 3.440

6.  Factors associated with the inflammatory process in pain in ankylosing spondylitis.

Authors:  Kaouther Maatallah; Yasmine Makhlouf; Hanene Ferjani; Ines Cherif; Dorra Ben Nessib; Wafa Triki; Dhia Kaffel; Wafa Hamdi
Journal:  Pan Afr Med J       Date:  2022-04-25

7.  Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Authors:  Maria G Tektonidou; Gkikas Katsifis; Athanasios Georgountzos; Athina Theodoridou; Eftychia-Maria Koukli; Anna Kandili; Giasna Giokic-Kakavouli; Theofilos-Diamantis Karatsourakis
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-09-28       Impact factor: 5.346

8.  Association of sleep disturbance with calcitonin, disease severity and health index among patients with ankylosing spondylitis.

Authors:  Chun-Hsiung Chen; Hung-An Chen; Hsien-Tzung Liao; Chen-Hung Chen
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

9.  Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset.

Authors:  Kathleen Tymms; Belinda E Butcher; Tracey L Sletten; Tegan Smith; Catherine O'Sullivan; Geoffrey Littlejohn; Ricky Sadler; Rebecca Tronnberg; Hedley Griffiths
Journal:  Clin Rheumatol       Date:  2021-11-26       Impact factor: 3.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.